SNDX

Conviction 21HealthcareScan · Mon, Aug 10, 2026

SNDX$20.38-0.10%

ResistanceSupportVol 14Insider sell

Vol MA14 1.53M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Syndax Pharmaceuticals IncPHARMACEUTICAL PREPARATIONSwww.syndax.com ↗

Price20.38

Change-0.10%

Gap-0.27%

Rel volume1.00×

Avg volume1.54M

Avg $ vol32.36M

SMA 2020.94

SMA 5020.41

SMA 20020.50

Price vs 50-0.14%

Price vs 200-0.59%

MA stackbearish

50/200 crossdeath · 4d

Supertrenddown · 22.09

RSI (14)48

MACD hist-0.09

MACD cross—

Stoch %K / %D57 / 52

ADX (14)28

+DI / −DI14 / 28

RSI divergence—

MACD divergence—

ATR %+5.32%

ADR %5.12%

52w high25.15

52w low12.48

From 52w high-18.97%

Above 52w low+63.30%

New 52w highNo

SqueezeOff

Bollinger width30.02%

%B0.41

Donchian pos44.11%

Donchian high24.41

Donchian low17.20

AVWAP (52w high)21.01

vs AVWAP high-2.98%

AVWAP (52w low)18.70

vs AVWAP low+8.99%

OBV trendDown

Chaikin MF (20)-0.06

Today vs 20d1.00×

Avg vol (14d)1.53M

Avg vol (20d)1.54M

Avg $ vol (20d)32.36M

Market cap1.82B

RS 3m (vs SPY)-6.38%

RS 6m (vs SPY)-12.87%

RS line new highNo

Trend template4/8

Technical rank33.4

1 week+5.93%

1 month-13.68%

3 months-5.17%

6 months-3.00%

1 year+60.22%

YTD-4.32%

P/E-6.38

P/B120.53

P/S10.56

P/FCF-5.63

EPS-3.29

Div yield—

ROE—

ROA-40.56%

Debt/Eq23.18

Current6.77

EV/EBITDA—

Gross margin—

Net margin-165.60%

Rev growth627.84%

EPS growth10.46%

Price target38.25

Target upside87.68%

Analyst ratingBuy

Institutional124.34%

Ent. value1.83B

Revenue72.79M

Net income-49.36M

Gross profit—

Free cash flow-323.17M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out88.61M

Employees298

ListedThu, Mar 3, 2016

Free float83.06M

Float %93.5%

Short interest20.82M

Days to cover9.8d

Short volume63.3%

Squeeze score81 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.55 vs −$0.45

Last surprise-22.2% miss

Setup gradeD

Conviction21 / 100

Pattern quality—

Tech rank33.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance24.83

Support17.92

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNDX

All disclosures →

No recent disclosed trades by Congress in SNDX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNDX · 2 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Metzger Michael A Chief Executive Officer · Common Stock · 2026-07-08	Exercise	32.38K	$207K	2026-07-08	2026-07-09
Metzger Michael A Chief Executive Officer · Common Stock · 2026-07-08	Sell	32.38K	$785K	2026-07-08	2026-07-09
Metzger Michael A Chief Executive Officer · Stock Option (Right to buy) · 2026-07-08	Exercise	32.38K	—	2026-07-08	2026-07-09
Goldan Keith A. Chief Financial Officer · Common Stock · 2026-06-01	Sell	1.18K	$22K	2026-06-01	2026-06-02
Metzger Michael A Chief Executive Officer · Common Stock · 2026-06-01	Sell	6.85K	$130K	2026-06-01	2026-06-02

SEC filings

EDGAR filings in SNDX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.